Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
6.77M
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
102K
-
Shares change
-
+34K
-
Total reported value, excl. options
-
$199K
-
Value change
-
+$66.6K
-
Number of buys
-
5
-
Number of sells
-
-2
-
Price
-
$1.94
Significant Holders of Tharimmune, Inc. - Common Stock (THAR) as of Q2 2025
9 filings reported holding THAR - Tharimmune, Inc. - Common Stock as of Q2 2025.
Tharimmune, Inc. - Common Stock (THAR) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 102K shares
of 6.77M outstanding shares and own 1.51% of the company stock.
Largest 9 shareholders include FRANKLIN RESOURCES INC (45K shares), GEODE CAPITAL MANAGEMENT, LLC (15.4K shares), UBS Group AG (15K shares), XTX Topco Ltd (12.9K shares), BRAVE ASSET MANAGEMENT INC (10K shares), Tower Research Capital LLC (TRC) (1.8K shares), SBI Securities Co., Ltd. (1.53K shares), Stone House Investment Management, LLC (500 shares), and BANK OF AMERICA CORP /DE/ (24 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.